| Decision | Consent granted Section 13(1)(a) Overseas Investment Act 2005 |
|---|---|
| Decision maker | Toitū Te Whenua Land Information New Zealand |
| Decision date | 15 September 2026 |
| Pathway | Primary Consent (Significant business asset) |
| Investment | Acquisition of up to 100% of the shares in NZCR Group Holdings Limited |
| Consideration | Withheld under section 9(2)(b)(ii) of the Official Information Act 1982 |
| Applicant | Trident NZ BidCo Limited United States of America 27% New Zealand 25% Singapore 6% Various 42% |
| Vendor | NZCR Group Holdings Limited New Zealand 92% United Kingdom 7% Australia 1% |
| Background | The Applicant is owned by funds managed and/or advised by Advent International L.P. The Applicant has entered into an agreement to acquire 100% of the shares in NZCR Group Holdings Limited. NZCR Group Holdings Limited administers clinical trials and conducts medical research in Auckland, Hamilton, Wellington, Christchurch and Adelaide. The Applicant intends to support the continued expansion of NZCR's clinical research and clinical trial activities. Consent was granted as the National Interest test was met. |
| More information | Ben Paterson Russell McVeagh (Auckland) PO Box 8 Auckland 1140 |